Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S appoints Sarah Mai Lykke-Kjeldsen as new COO
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: CFO Mads Møller Kristensen and DanCann Pharma will be parting ways as of 31 May 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: Postponement of the Annual General Meeting of shareholders
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S named "Entrepreneur of the Year 2021" in Varde Municipality
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S publishes Q4-2021 report
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: 26-year-old Jeppe Krog Rasmussen, CEO of DanCann Pharma A/S, listed as one of the greatest business management talents in Denmark by leading Danish newspaper Berlingske
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S has submitted application to the Danish Medicines Agency for EU-GMP-approval for Biotech Pharm1
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S has submitted application to the Danish Medicines Agency for EU-GMP-approval for Biotech Pharm1
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: Highly promising analysis results
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Dancann Pharma

Press release from Companies: DanCann Pharma A/S: Highly promising analysis results